MARKET

IOVA

IOVA

Iovance Biotherp
NASDAQ
8.03
-0.05
-0.62%
Opening 14:08 11/11 EST
OPEN
8.15
PREV CLOSE
8.08
HIGH
8.19
LOW
8.01
VOLUME
4.22M
TURNOVER
--
52 WEEK HIGH
15.37
52 WEEK LOW
2.080
MARKET CAP
3.72B
P/E (TTM)
-15.4661
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Immutep (IMMP) and Iovance Biotherapeutics (IOVA)
TipRanks · 5h ago
Weekly Report: what happened at IOVA last week (1102-1106)?
Weekly Report · 2d ago
Biotech Is Booming; Here Are 4 Names Outperforming Despite This Deep Correction
Seeking Alpha · 2d ago
Iovance Biotherapeutics Is Maintained at Overweight by Barclays
Dow Jones · 5d ago
Iovance Biotherapeutics Price Target Raised to $19.00/Share From $18.00 by Barclays
Dow Jones · 5d ago
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $19
Benzinga · 5d ago
Iovance Biotherapeutics Price Target Raised to $12.00/Share From $8.00 by Citizens
Dow Jones · 5d ago
Iovance Biotherapeutics Is Maintained at Market Outperform by Citizens
Dow Jones · 5d ago
More
About IOVA
Iovance Biotherapeutics, Inc. is a commercial biotechnology company. The Company is focused on developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. Its products include Amtagvi and Proleukin. Amtagvi is indicated for the treatment of adult patients with melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor. It is marketing Proleukin (aldesleukin), an interleukin-2 (IL-2) product used in the Amtagvi treatment regimen and in other applications. Amtagvi and Proleukin are part of a treatment regimen that includes lymphodepletion. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings and indications for solid tumor cancers. Its TIL therapy includes melanoma, non-small cell lung cancer and gynecologic cancer.

Webull offers Iovance Biotherapeutics Inc stock information, including NASDAQ: IOVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IOVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IOVA stock methods without spending real money on the virtual paper trading platform.